VANTAGEPOINT INVESTMENT ADVISERS LLCVANTAGEPOINT INVESTMENT ADVISERS LLC

Institutional investor · Portfolio as of Q2 2022

SEC EDGAR SourceSEC Filings

Top Holdings9 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction
IVVIVV
ETF

ISHARES CORE S&P 500 ETF

677,590$256.9M42.9%$373.02-2.67%
9 qtrssince 2020-Q2
Increased
77
AGGAGG
ETF

ISHARES TR

880,131$89.5M15.0%$98.46-10.78%
9 qtrssince 2020-Q2
Decreased
0
TLTTLT
ETF

ISHARES 20 PLUS YEAR TREASURY BD

558,360$64.1M10.7%$97.890.00%
1 qtr
New
94
VWOVWO
ETF

VANGUARD FTSE EMERGING MARKETS

1.5M$60.9M10.2%$36.900.00%
1 qtr
New
94
IWDIWD
ETF

ISHARES TR RUSSELL 1000 VALUE INDEX FUND

216,300$31.4M5.2%$135.920.00%
1 qtr
New
92
??VANGUARD BD INDEX FDSDelisted
Bond
360,620$27.7M4.6%
1 qtr
New
83
VCSHVCSH
ETF

VANGUARD S/T CORP BOND ETF

360,050$27.5M4.6%$65.380.00%
1 qtr
New
83
VTVVTV
ETF

VANGUARD VALUE ETF

201,200$26.5M4.4%$121.520.00%
1 qtr
New
82
IGSBIGSB
ETF

ISHARES 1-5Y INV GRADE CORP

269,710$13.6M2.3%$43.140.00%
1 qtr
New
75
$598.2M
AUM
9
Positions
Q2 2022
Filing
Rating · 1.0
Quarterly Portfolio Change
Not enough history yet
Activity profile
$ moved · Q2'22
New87%Increased5%Decreased8%Exited0%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.4 years
<1Q56%1-4Q0%1-2Y0%2Y+44%

VANTAGEPOINT INVESTMENT ADVISERS LLC manages $598.2M across 9 positions as of Q2 2022. Top holdings: IVV (42.9%), AGG (15.0%), TLT (10.7%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 1/5.0.

Q2 2022 Summary

Active quarter - 7 new positions, 0 exits, 1 increased. Top move: TLT (NEW, conviction 94). Portfolio: $598M across 9 positions.

Top holdings by portfolio weight

Total AUM$598M
IVV42.95%
AGG14.96%
TLT10.72%
VWO10.19%
IWD5.24%
VANGUARD BD 4.63%
VCSH4.59%
VTV4.44%
IGSB2.28%

Portfolio allocation by GICS sector

Sectors1
Unknown100.00%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Unknown
Compare DNA across all funds
7-dimension quality assessment
Weak(1.0 / 5.0)
Track RecordNo data
Conviction50
Concentration51
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Top Losers

Checking access…

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
4Q
VUGVUGVANGUARD GROWTH ETF
Q3 2025 Q2 2026+6.8M shares+$581.2M
3Q
AVEMAVEMAVANTIS EMERGING MARKETS EQ
Q4 2025 Q2 2026+126,777 shares+$60.7M
2Q
VWOVWOVANGUARD FTSE EMERGING MARKETS
Q1 2026 Q2 2026+521,392 shares+$44.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used